Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas
Clinical trial NCT01748149 · COMPLETED
Trial details
- NCT number
- NCT01748149
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-29
- Primary completion
- 2018-12-05
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.